Saturday, September 2
LivaNova Satellite Symposium, 15:30-17:00, Room A
Title: Heart, Body & Mind | Epilepsy and the Autonomic Nervous System
| Chair: Richard Verrier, United States | |
| Autonomic Phenomena in People with Epilepsy | Brian D. Moseley, United States |
| T-wave Alternans and Cardiac Pathology in Epilepsy | Richard Verrier, United States |
| SUDEP - The Ultimate Autonomic Breakdown | Rainer Surges, Germany |
GW Pharmaceuticals Satellite Symposium, 15:30-17:00, Room F
Title: Perspectives in Early-Onset Epilepsies: Patients, Physicians and Possibilities
| Chair: Helen Cross, United Kingdom Host: Hari Bhathal, Spain | |
| Early-Onset Epilepsies: The Patient Perspective | Isabella Brambilla, Italy |
| Early-Onset Epilepsies: The Societal Perspective | Sameer Zuberi, United Kingdom |
| Early-Onset Epilepsies: The Clinical Perspective | Victoria San Antonio-Arce |
| Panel Discussion and Audience Q&A | |
Sunday, September 3
Elekta Satellite Symposium, 08:00-09:30, Room F
Title: Source Localization and Network Analysis with MEG and EEG
| Chair: Paul Boon, Belgium | |
| MEG and EEG Source Localization | Evelien Carette, Belgium |
| Networks and Clinical Implications | Hermann Stefan, Germany |
| MEG in Clinical Use, Experiences in Spain | Leonides Canuet Delis, Spain |
Zogenix Satellite Symposium, 16:30-18:00, Room A
Title: Recognising the Burdens of Dravet Syndrome: Co-Morbidities, Mortality, SUDEP
| Chair: Lieven Lagae, Belgium | |
| Chairman"s Introduction | Lieven Lagae, Belgium |
| Dravet Syndrome: Impact Beyond Seizures | Alexis Arzimanoglou, France |
| Co-Morbidities: Real Life Insights | Lieven Lagae, Belgium |
| The Burdens: Current Challenges | Ley Sander, United Kingdom |
| Panel Discussion | |
BioMarin Satellite Symposium, 18:00-19:30, Congress Hall
Title: A Time Critical Genetic Epilepsy - New Data for Diagnosing and Managing Children with CLN2 Disease
| Chair: Angela Schulz, Germany | |
| A New Era for CLN2 disease: Natural History and New Data for Clinical Management | Angela Schulz, Germany |
| Epilepsy Neurogenetics: Earlier Diagnosis of CLN2 Disease in Clinical Practice | Raman Sankar, United States |
| EEG and Clinical Clues: Identifying CLN2 Disease Within Early-Onset Myoclonic Epilepsies | Nicola Specchio, Italy |
| Discussion: Minimising Diagnostic Delay in CLN2 | |
Eisai Satellite Symposium, 18:10-19:40, Room F
Title: Mechanisms Behind Tumour Growth and Epileptic Activity in Brain Tumours; Discussion of the AMPA Receptor Pathway and Clinical Implications
| Co-Chairs: Matthew Walker, United Kingdom Riccardo Soffietti, Italy |
|
| Can We Be Better at Treating Seizures in Patients with Brain Tumour-Related Epilepsy? | Gilles Huberfeld, France |
| Why Do We Need to Understand the Glutamatergic Mechanisms in Brain Tumour-Related Epilepsy? | Mark Cunningham, United Kingdom |
| It's Time to Conduct Brain Tumor-Related Epilepsy Trials! | Terence O"Brien, Australia |
Monday, September 4
Medtronic Satellite Symposium, 08:00-09:30, Room H2
Title: Advancing Treatment Options for Drug-Resistant Epilepsy Patients
MRI-Guided Laser Ablation & Deep Brain Stimulation
| Chair: Thomas Brionne, Switzerland | |
| Minimally Invasive MRI-Guided Laser Ablation | Michael Sperling, United States |
| New Insights into Mechanisms of Action for ANT-DBS | Liankun Ren, China |
| Future Directions in Deep Brain Stimulation for Epilepsy | Thomas Brionne, Switzerland |
GW Pharmaceuticals Satellite Symposium, 18:00-19:30, Room J
Title: Moving On: Patients with Early-Onset Epilepsies and the Transition to Adult Care
| Chair: Antonio Gil-Nagel, Spain | |
| Anything But Child's Play: Early-Onset Epilepsies | Nicola Specchio, Italy |
| Challenges Faced by Adult Epileptologists: Transitioning Patients with Early-Onset Epilepsies | Bernhard J. Steinhoff, Germany |
| Taking the First Step: Models of Care with Clonazepam for Transitional Services | Rima Nabbout, France |
| Panel Discussion and Audience Q&A | |
Tuesday, September 5
Eisai-Bial Satellite Symposium, 18:00-19:30, Room J
Title: Optimising Epilepsy Therapy: Trials, Tribulations, Evidence and Experience… Do We Really Know Our AEDs?
| Chair: Martin Holtkamp, Germany | |
| Introduction to AED Trial Programs | Martin Holtkamp, Germany |
| Robust Clinical Trial Programs Give Us the Best Insight Into our AEDs | Mar Carreño, Spain |
| Real World Studies Give Us the Best Insight Into our AEDs | Vicente Villanueva, Spain |
The Faces of Lafora - Documentary Screening, 18:00-19:30, Room F
